Anavex Appoints Leading Alzheimer’s Disease Expert Dr. Mark Smith to Scientific Advisory Board

Athens, Greece — February 10, 2009 — Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) today announced the appointment of Dr. Mark A. Smith, Ph.D., FRCPath, to its scientific advisory board. Dr. Smith is recognized as one of the world’s most cited researchers in the fields of Alzheimer’s disease, free radical biology and neuroscience and behavior.…